Advanced Fermentation Platforms Professional CDMO Service GMP-Compliant Pharmaceutical Purity Premium API Retatrutide API Retatrutide is an experimental drug for obesity, it is a triple glucagon hormone receptor agonist (including GLP-1, GIP, GCGR receptors)
There is also a molecule-level nuance
Most people find the best results after 24 weeks of daily, consistent use
GIP and GLP-1 have well-established roles in regulating glucose and energy metabolism, whereas GLP-2 is better known for intestinotrophic actions
Consistent with the results of GGCT knockdown in vitro, depletion of GGCT significantly reduced tumor volume and weight compared with control groups
If untreated, they may cause intestinal tissue to die and can lead to abdominal infections